280 related articles for article (PubMed ID: 15381690)
1. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).
Hanford LE; Enghild JJ; Valnickova Z; Petersen SV; Schaefer LM; Schaefer TM; Reinhart TA; Oury TD
J Biol Chem; 2004 Nov; 279(48):50019-24. PubMed ID: 15381690
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris.
Ostendorp T; Weibel M; Leclerc E; Kleinert P; Kroneck PM; Heizmann CW; Fritz G
Biochem Biophys Res Commun; 2006 Aug; 347(1):4-11. PubMed ID: 16806067
[TBL] [Abstract][Full Text] [Related]
3. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.
Zhang H; Mao YF; Zhao Y; Xu DF; Wang Y; Xu CF; Dong WW; Zhu XY; Ding N; Jiang L; Liu YJ
Oxid Med Cell Longev; 2021; 2021():8889313. PubMed ID: 33628393
[TBL] [Abstract][Full Text] [Related]
5. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D
J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene.
Kalea AZ; Reiniger N; Yang H; Arriero M; Schmidt AM; Hudson BI
FASEB J; 2009 Jun; 23(6):1766-74. PubMed ID: 19164451
[TBL] [Abstract][Full Text] [Related]
7. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.
Geroldi D; Falcone C; Emanuele E
Curr Med Chem; 2006; 13(17):1971-8. PubMed ID: 16842191
[TBL] [Abstract][Full Text] [Related]
8. Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction.
Bonetti TC; Borges E; Braga DP; Iaconelli A; Kleine JP; Silva ID
Reprod Biomed Online; 2013 Jan; 26(1):62-7. PubMed ID: 23182743
[TBL] [Abstract][Full Text] [Related]
9. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
Lee D; Lee KH; Park H; Kim SH; Jin T; Cho S; Chung JH; Lim S; Park S
PLoS One; 2013; 8(8):e69669. PubMed ID: 23936343
[TBL] [Abstract][Full Text] [Related]
10. The receptor for advanced glycation end products (RAGE) and the lung.
Buckley ST; Ehrhardt C
J Biomed Biotechnol; 2010; 2010():917108. PubMed ID: 20145712
[TBL] [Abstract][Full Text] [Related]
11. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
12. Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker.
Yamagishi S; Matsui T
Front Biosci (Elite Ed); 2010 Jun; 2(4):1184-95. PubMed ID: 20515790
[TBL] [Abstract][Full Text] [Related]
13. Clearance kinetics and matrix binding partners of the receptor for advanced glycation end products.
Milutinovic PS; Englert JM; Crum LT; Mason NS; Ramsgaard L; Enghild JJ; Sparvero LJ; Lotze MT; Oury TD
PLoS One; 2014; 9(3):e88259. PubMed ID: 24642901
[TBL] [Abstract][Full Text] [Related]
14. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S; Matsui T; Nakamura K
Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
[TBL] [Abstract][Full Text] [Related]
15. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.
Guo WA; Knight PR; Raghavendran K
Intensive Care Med; 2012 Oct; 38(10):1588-98. PubMed ID: 22777515
[TBL] [Abstract][Full Text] [Related]
16. Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein.
Marsche G; Weigle B; Sattler W; Malle E
FASEB J; 2007 Oct; 21(12):3075-82. PubMed ID: 17536039
[TBL] [Abstract][Full Text] [Related]
17. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.
Lee EJ; Park EY; Mun H; Chang E; Ko JY; Kim DY; Park JH
FASEB J; 2015 Aug; 29(8):3506-14. PubMed ID: 25934702
[TBL] [Abstract][Full Text] [Related]
18. Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation.
Lanati N; Emanuele E; Brondino N; Geroldi D
Curr Vasc Pharmacol; 2010 Jan; 8(1):86-92. PubMed ID: 19485931
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer.
Jing R; Cui M; Wang J; Wang H
Neoplasma; 2010; 57(1):55-61. PubMed ID: 19895173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
